EXTON, Pa., Feb. 3, 2012 /PRNewswire/ -- Kensey Nash
Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord
Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012 at Parc 55 in
San Francisco, California.
Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver
the Company's presentation, beginning approximately at 10:40 a.m. (PT). The presentation materials
will be available on the company's website (www.kenseynash.com)
beginning at 10:40 a.m. (PT) on
Tuesday, February 7, 2012. The
Canaccord Genuity Musculoskeletal Conference will be available by
webcast. To listen to the webcast, go to
http://event.on24.com/r.htm?e=396242&s=1&k=312B05B671DBD80BD74903D373C807ED.
About Kensey Nash Corporation. Kensey Nash
Corporation is a medical device company primarily focused on
regenerative medicine utilizing its proprietary collagen and
synthetic polymer technology. The Company is recognized as a
leader for innovative product development and unique technology in
the field of resorbable biomaterials. The Company has an
extensive range of products, which are sold through strategic
partners in multiple medical markets, including the cardiology,
orthopaedic, sports medicine, spine, endovascular and general
surgery markets.
SOURCE Kensey Nash Corporation